Black Rock Inc. Exelixis, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 33,502,228 shares of EXEL stock, worth $899 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,502,228
Previous 34,882,633
3.96%
Holding current value
$899 Million
Previous $828 Million
9.06%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Vanguard Group Inc Valley Forge, PA29.7MShares$796 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$727 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$407 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$338 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL5.76MShares$155 Million0.28% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.63B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...